FSS

For just over a year, the federal government has been running a strange experiment in technology procurement. Through its OneGov program, the General Services Administration (GSA) put leading enterprise artificial intelligence (AI) platforms in agencies’ hands for $1 or less. Three of those offers were set to expire on September 30, 2026.

Now we know what comes next, at least for one of them. On September 10, GSA announced the first agreement in the next phase of its OneGov AI strategy. The $1 price was replaced by a 27-month consumption-based arrangement running from October 1, 2026, through December 31, 2028. During this period, agencies pay no platform fee and make no minimum commitment, but they pay for usage at 50% off token-based pricing. Usage eligibility extends not only to all three federal branches but also to state, local, and tribal governments. GSA notes that the deal includes a one-year check-in and requires providers to report utilization and cost-savings data (feeling very transactional data reporting-esque).

So the free trial isn’t exactly over, but the flat price that never rose with use is gone. That changes the question for agencies. It’s no longer about whether to try it; it’s about what the technology costs at scale and what it would cost to exit.

Continue Reading The $1 AI Honeymoon Is Over, and GSA Has Drafted a Postnup

UPDATE: The Safer Federal Workforce Task Force issued updated Guidance on November 10 confirming that the date a covered employee must be fully vaccinated is January 18, 2022.

With the addition of new answers to frequently asked questions (FAQs) on November 1, and the November 4 “Fact Sheet” issued by the White House accompanying the rollout of the Department of Labor’s Occupational Safety and Health Administration (OSHA) and Centers for Medicare & Medicaid Services (CMS) vaccination requirements for, respectively, employers with 100 or more employees and health care workers and facilities participating in Medicare and Medicaid, federal contractors have been given additional breathing room to address recalcitrant covered employees who are resisting the vaccination mandate.Continue Reading Important Updates on Federal Contractor Vaccine Mandate—Deadline Extended and Flexibility Added

The General Services Administration (GSA) released its Class Deviation CD-2021-13 (the GSA Deviation), which, effective immediately, “provides instructions for the GSA acquisition workforce on when to include a new clause [i.e., Federal Acquisition Regulation (FAR) 52.223-99] (the Clause) in GSA solicitations and contracts and contract-like instruments.” Unlike the recent instructions and directions provided by the Civilian Agency Acquisition Council (CAAC) and the Department of Defense (DoD) and its DFARS Class Deviation (discussed in detail here), the GSA provided “GSA-specific implementation timelines for solicitations, new contracts, and existing contracts” to ensure that by October 8, 2021, all covered solicitations, new contracts, and existing contracts subject to Executive Order 14042, “Ensuring Adequate COVID Safety Protocols for Federal Contractors” (EO 14042), adhere to its mandates and the evolving guidance issued by the Safer Federal Task Force. This implementation includes the insertion of the Clause into new and existing GSA solicitations and Federal Supply Schedule (FSS) contracts awarded after October 15, 2021, and new contracts and leases awarded after November 14, 2021. The instruction applies broadly even to solicitations or contracts that have a value equal to or less than the simplified acquisition threshold (SAT) or are for the supply of products (either solely for products or for products and services). Moreover, the GSA is instructing its contracting officers to issue a letter to all existing contractors asking for their consent to a modification including the Clause. The end result is the expectation that virtually all GSA contracts and contract-like instruments will require all covered employees to be fully vaccinated by December 8, 2021. An analysis of the GSA Deviation’s key points, highlighting the confusion related to subcontract flow-downs, follows below.
Continue Reading This Will Only Hurt a Bit: The GSA Mandates COVID-19 Vaccines in Nearly All Existing Contract Types